Astec LifeSciences Limited (ASTEC)

1,051

INR
-34.10(-3.14%)
As of December 26, 2024 9:59:00 AM

About Astec LifeSciences Limited

Astec LifeSciences Limited, together with its subsidiaries, engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India. It offers triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. The company also provides herbicides, insecticides, and specialty chemical products. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
5.68
Operating MarginLast 12 months
-31.67
+0% quarterly YoY
Market Cap
2118.33 CrINR
Employees
606
CEO
Mr. Anurag Roy
Website

Astec LifeSciences Limited (ASTEC)

1,051

INR
-34.10(-3.14%)
As of December 26, 2024 9:59:00 AM

About Astec LifeSciences Limited

Astec LifeSciences Limited, together with its subsidiaries, engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India. It offers triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. The company also provides herbicides, insecticides, and specialty chemical products. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
5.68
Operating MarginLast 12 months
-31.67
+0% quarterly YoY
Market Cap
2118.33 CrINR
Employees
606
CEO
Mr. Anurag Roy
Website